Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT06027437 Completed - Healthy Volunteers Clinical Trials

A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants

Start date: September 5, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the relative biological availability and the effect of food on the drug levels of Danicamtiv in health adults.

NCT ID: NCT06025396 Completed - Healthy Volunteers Clinical Trials

Multiple Ascending Dose Study of TMP-301 in Healthy Subjects

Start date: January 6, 2023
Phase: Phase 1
Study type: Interventional

A PHASE 1, RANDOMIZED, PLACEBO CONTROLLED, MULTIPLE ASCENDING DOSE (MAD) STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF TMP-301 IN HEALTHY SUBJECTS.

NCT ID: NCT06024239 Recruiting - Healthy Volunteers Clinical Trials

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD)

Start date: August 31, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the pharmacokinetics, safety, and tolerability following multiple ascending oral doses of ABBV-932 or placebo in healthy adult participants, participants with Generalized Anxiety Disorder (GAD), and participants with bipolar disorder (BPD).

NCT ID: NCT06022354 Recruiting - Healthy Volunteers Clinical Trials

To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects

Start date: August 23, 2023
Phase: Phase 1
Study type: Interventional

This is a Phase 1, randomized, double-blind, placebo-controlled trial of SIM0278 in healthy subjects. The study will be conducted in 2 parts. Part 1 is single ascending dose study. Part 2 is multiple ascending dose study.

NCT ID: NCT06019065 Active, not recruiting - Healthy Volunteers Clinical Trials

A SAD, MAD and Food Effect Study to Evaluate the Safety, Tolerability, PK, and PD of AJA001 in Healthy Subjects

Start date: September 13, 2023
Phase: Phase 1
Study type: Interventional

This is a Phase 1, double-blind, randomized, placebo- controlled, SAD and MAD study to assess safety, tolerability, PK, and PD of AJA001 in fasted healthy participants. Food effect will be evaluated in one cross-over SAD fed dose cohort.

NCT ID: NCT06010589 Active, not recruiting - Healthy Volunteers Clinical Trials

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult Volunteers

Start date: August 17, 2023
Phase: Phase 1
Study type: Interventional

This study aims to compare the pharmacokinetics and safety following administration of DWJ1558 and co-administration of DWC202310 and DWC202311 in healthy volunteers.

NCT ID: NCT06009237 Terminated - Healthy Volunteers Clinical Trials

A Study to Assess Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese Participants

Start date: August 23, 2023
Phase: Phase 1
Study type: Interventional

The objective of this study is to assess the pharmacokinetics (PK), safety, and tolerability of ABBV-903 or placebo in healthy adult Japanese and Han Chinese subjects.

NCT ID: NCT06000163 Not yet recruiting - Healthy Volunteer Clinical Trials

Normal Reference Values in Han Adults of Skin Thickness and Blood Flow by High-frequency Ultrasound

NOVAS-HFUS
Start date: September 1, 2023
Phase:
Study type: Observational

In recent years, high-frequency ultrasound has become a new non-invasive tool for the diagnosis of skin diseases, aesthetic medicine and preoperative and postoperative evaluation due to its higher resolution. The purpose of this multi-center Study is to establish the normal reference values of skin thickness and blood flow parameters by high-frequency ultrasound in Chinese Han adults, and to explore the influencing factors, so as to provide quantitative reference for the evaluation of facial skin aging degree and cosmetic treatment.

NCT ID: NCT05999942 Completed - Healthy Volunteers Clinical Trials

A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants

Start date: June 2, 2004
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is to determine the intra and extra pulmonary deposition and clearance of inhaled amikacin-loaded liposomes by gamma scintigraphy in healthy male participants.

NCT ID: NCT05995691 Completed - Healthy Volunteers Clinical Trials

Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Japanese Participants

Start date: November 24, 2014
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to determine the bioequivalence of ABP 501 (subcutaneous [SC] injection) compared to adalimumab (SC injection) as assessed principally by the area under the serum concentration-time curve from time 0 extrapolated to infinity (AUCinf), and maximum observed serum concentration (Cmax) in Japanese participants.